BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28252631)

  • 1. [Myeloproliferative masks of multiple myeloma: A review of literature and clinical case reports].
    Ryzhko VV; Grachev AE; Klodzinsky AA; Ivanova TV; Sataeva MS; Gribanova EO
    Ter Arkh; 2017; 89(1):72-77. PubMed ID: 28252631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant or benign leukocytosis.
    George TI
    Hematology Am Soc Hematol Educ Program; 2012; 2012():475-84. PubMed ID: 23233622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloproliferative disorders and the hyperviscosity syndrome.
    Adams BD; Baker R; Lopez JA; Spencer S
    Emerg Med Clin North Am; 2009 Aug; 27(3):459-76. PubMed ID: 19646648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concurrence of multiple myeloma and idiopathic erythrocytosis.
    Chang H; Shih LY
    Acta Clin Belg; 2009; 64(5):434-5. PubMed ID: 19999392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic myelocytic leukemia and the myeloproliferative diseases during the child-bearing years.
    Miller JB
    J Reprod Med; 1976 Oct; 17(4):217-24. PubMed ID: 1068296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.
    Rachmilewitz B; Rachmilewitz M
    Isr J Med Sci; 1977 Jul; 13(7):710-5. PubMed ID: 270474
    [No Abstract]   [Full Text] [Related]  

  • 7. [Myeloproliferative syndrome, myelofibrosis and erythrocytosis. A retrospective study].
    Retief FP; Du P Heyns A
    S Afr Med J; 1974 Dec; 48(59):2429-35. PubMed ID: 4532812
    [No Abstract]   [Full Text] [Related]  

  • 8. The differential diagnostic significance of bone-marrow biopsy in haemoblastoses.
    Nagy G; Krasznai G; Léhi M; Szegedi J
    Acta Morphol Acad Sci Hung; 1973; 21(1):79-88. PubMed ID: 4517967
    [No Abstract]   [Full Text] [Related]  

  • 9. Some uses of the continuous flow blood separator in the myeloproliferative syndrome.
    Bell R; Sullivan JR; Hurley TH; D'Apice AJ; Kincaid-Smith P
    Aust N Z J Med; 1978 Aug; 8(4):433-5. PubMed ID: 282861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraneoplastic leukemoid reactions induced by cytokine-secreting tumours.
    Abukhiran IA; Jasser J; Syrbu S
    J Clin Pathol; 2020 Jun; 73(6):310-313. PubMed ID: 31941653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A "myeloproliferative syndrome" of long duration (author's transl)].
    Kühböck J; Peskar BM; Vormittag W
    Med Klin; 1974 Mar; 69(10):423-6. PubMed ID: 4524608
    [No Abstract]   [Full Text] [Related]  

  • 12. Rapid determination of vitamin B12-binding alpha- and beta-globulin in serum.
    Silverstein E; Herbert V
    Blood; 1968 Apr; 31(4):518-21. PubMed ID: 4171463
    [No Abstract]   [Full Text] [Related]  

  • 13. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
    Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
    Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloproliferative syndrome in childhood.
    Penchansky L; Krause JR
    Pediatr Pathol; 1983; 1(3):311-8. PubMed ID: 6593700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoproliferative and myeloproliferative disorders.
    Savage CJ
    Vet Clin North Am Equine Pract; 1998 Dec; 14(3):563-78, vii. PubMed ID: 9891725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the diagnostic significance of hemoglobin F levels.
    Newman DR; Pierre RV; Linman JW
    Mayo Clin Proc; 1973 Mar; 48(3):199-202. PubMed ID: 4511337
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic importance of blood histamine levels in myeloproliferative diseases].
    Gingold N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1980; 32(6):541-6. PubMed ID: 6113673
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
    Vilcu A; Hossu T; Popescu ID; Câmpeanu L
    Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
    [No Abstract]   [Full Text] [Related]  

  • 19. [The treatment of myeloproliferative syndromes].
    Maurice P
    Schweiz Med Wochenschr; 1975 Oct; 105(40):1269-74. PubMed ID: 1061995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myeloid leukocytoses.
    Ward PC
    Postgrad Med; 1980 Jan; 67(1):219-21, 224-6, 229. PubMed ID: 7350563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.